U.S. Physical Therapy, Inc. — Form 8-K Summary
Reporting event: The company reported entering into a forward-starting interest rate swap on September 22, 2026. The 8-K was signed on September 28, 2026. This filing reports a financing transaction, not periodic operating results.
Material transaction and financial terms
- The 45-month swap with Bank of America has an initial notional amount of $170.6 million and is intended to hedge the variable-rate component of the company’s term debt under its April 14, 2026 Credit Agreement.
- Effective June 30, 2027, when the existing swap expires, the company will pay a fixed rate of 4.578% per annum and receive payments based on one-month SOFR on the same notional amount.
- The swap amortizes in line with the term-loan payment schedule and terminates April 14, 2031. The stated notional reflects scheduled term-loan amortization as of the swap’s effective date.
- Bank of America is also administrative agent and a lender under the Credit Agreement. The swap is subject to the parties’ existing ISDA Master Agreement.
Financial performance and comparison
The filing does not provide revenue, profit, cash flow, margins, liquidity, or total debt figures, nor does it report comparable-period operating results. It does not quantify expected interest savings, hedge effectiveness, or the swap’s fair value.
Outlook, risks, and contingencies
The transaction is designed to fix the variable interest component on the covered debt beginning June 30, 2027; it does not fix the company’s entire borrowing cost or disclose the applicable credit spread. Actual payments and economic results may depend on SOFR, debt balances, and the Credit Agreement’s amortization schedule. The filing states that its descriptions of the agreements are qualified by the full exhibit texts.
Important facts for investors to verify
- Review Exhibits 10.1 and 10.2 for the complete ISDA terms, swap provisions, and any relevant termination or payment terms.
- Compare the $170.6 million initial notional and amortization schedule with term-loan balances and scheduled repayments under the Credit Agreement.
- Check subsequent disclosures for the existing swap’s expiration, the new swap’s commencement, and any changes to the debt or hedge.
- Assess the company’s total borrowing cost, including the debt spread and any amounts not covered by the swap.